Sign In
Buy CHE
$444.11
+8.04 (+1.84%)
At Close: Jun 23, 2026
Chemed (CHE) Q3 Earnings Surpass Estimates
10:25pm, Monday, 31'st Oct 2022 Zacks Investment Research
Chemed (CHE) delivered earnings and revenue surprises of 2.82% and 1.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemed (CHE) Q3 Earnings Surpass Estimates
07:34pm, Monday, 31'st Oct 2022
Chemed (CHE) delivered earnings and revenue surprises of 2.82% and 1.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemed Corporation to Present at the 2022 Credit Suisse Healthcare Conference
12:00pm, Monday, 31'st Oct 2022
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 31st Annual Credit Suisse Healthcare Conference on Wednesday, November 9, 2022, at
Why Chemed (CHE) is Poised to Beat Earnings Estimates Again
04:10pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
Chemed (CHE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Chemed (CHE) is Poised to Beat Earnings Estimates Again
01:33pm, Wednesday, 26'th Oct 2022
Chemed (CHE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Earnings Preview: Chemed (CHE) Q3 Earnings Expected to Decline
02:00pm, Monday, 24'th Oct 2022 Zacks Investment Research
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 27 stocks can give you a more diversified portfolio than the S&P 500 -- and that's a key advantage right now
12:30pm, Saturday, 22'nd Oct 2022 MarketWatch
The Natixis Vaughan Nelson Select Fund and its ETF counterpart are more diversified than the S&P 500 because of factor analysis.
Chemed To Report Third-Quarter 2022 Earnings October 31, Related Conference Call To Be Held On November 1
12:00pm, Monday, 17'th Oct 2022
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2022, on Monday, October 31, 2022, followin
Is the Options Market Predicting a Spike in Chemed (CHE) Stock?
12:38pm, Friday, 07'th Oct 2022 Zacks Investment Research
Investors need to pay close attention to Chemed (CHE) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Chemed (CHE) Stock?
09:47am, Friday, 07'th Oct 2022
Investors need to pay close attention to Chemed (CHE) stock based on the movements in the options market lately.
Here's Why You Should Retain Chemed (CHE) Stock for Now
04:49pm, Thursday, 06'th Oct 2022 Zacks Investment Research
Investors are optimistic about Chemed's (CHE) Roto-Rooter business, which is witnessing continued demand for plumbing, drain cleaning services and water restoration services.
Here's Why You Should Retain Chemed (CHE) Stock for Now
02:18pm, Thursday, 06'th Oct 2022
Investors are optimistic about Chemed's (CHE) Roto-Rooter business, which is witnessing continued demand for plumbing, drain cleaning services and water restoration services.
Option Care (OPCH) Stock Jumps 8.9%: Will It Continue to Soar?
02:24pm, Thursday, 29'th Sep 2022 Zacks Investment Research
Option Care (OPCH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the
Chemed (CHE) Roto-Rooter Business Grows, VITAS Admission Dips
03:41pm, Wednesday, 28'th Sep 2022 Zacks Investment Research
The performance of Chemed's (CHE) VITAS business is somewhat offset by a geographically weighted average Medicare reimbursement rate increase.
Chemed (CHE) Roto-Rooter Business Grows, VITAS Admission Dips
12:47pm, Wednesday, 28'th Sep 2022
The performance of Chemed's (CHE) VITAS business is somewhat offset by a geographically weighted average Medicare reimbursement rate increase.
